PBS News

Price increases for 1 April 2012

21 February 2012

As announced by the Minister for Health on 21 February 2012, the Government has agreed to increase the price of 17 medicines currently listed on the PBS, as recommended by the Pharmaceutical Benefits Pricing Authority at its December 2011 meeting.

Aluminium with magnesium oral suspension (Mylanta P®)


Antacid used to treat reflux disease and heartburn


Bisacodyl suppositories (Dulcolax®)


For supplies under the Paraplegic and Quadriplegic program for the treatment of constipation


Carbohydrate, fat, vitamins, minerals & trace elements powder (Energivit®)


Specialised food for infants and children on a protein restricted diet


Erythromycin capsules (Eryc®)



Flurbiprofen eye drops (Ocufen®)


Analgesic and anti-inflammatory eye drop

Foscarnet sodium intravenous infusion (Foscavir®)


Treatment for viral eye and other viral infections in patients with HIV infection or AIDS

Glipizide tablet (Melizide®)


Treatment for type II diabetes

High fat formula with vitamins, minerals & trace elements powder (KetoCal®)


Specialised food for children with intractable epilepsy

Homatropine hydrobromide eye drops (Isopto Homatropine®)


Eye drop which dilates the pupil and is used before and after eye surgery 


Hydrocortisone tablets (Hysone®)


Treatment for Addison’s disease

Indapamide tablets, slow release (Natrilix SR®)


Treatment for high blood pressure

Isoniazid tablets (Isoniazid Fawns and McAllan)


Treatment for tuberculosis

Ondansetron syrup (Zofran Syrup®)


Used to prevent and treat nausea and vomiting during cancer chemotherapy and radiotherapy particularly in children


Oxazepam tablets (Alepam®)


Treatment for anxiety

Pindolol tablets (Barbloc 5®)


Treatment for high blood pressure

Ranitidine syrup (Zantac Syrup®)


Treatment for severe reflux in a paediatric formulation


Sterculia with frangula bark granules (Normacol Plus®)


Treatment for constipation